Dr Scott Tagawa discusses how dose adjustments can optimize the use of enfortumab vedotin in urothelial cancer.

Researchers analyzed data on 215 women diagnosed with stages 0-III breast cancer between January 2000 and October 2024 who ...

New dyslipidemia guidance from the American Association of Clinical Endocrinology focuses on newer medications and patient-important outcomes.

A prehospital blood test may rapidly distinguish between ischemic and hemorrhagic strokes, potentially enabling more timely, ...

Although it may feel good in the moment, a repetitive cycle of boosting your cortisol levels and seeking solace in food can ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.

Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.

The clinical practice update offers 12 “best practice advice” statements on POEM to treat achalasia and other esophageal ...

A real-world Danish registry study showed a significant increased relative risk, but small absolute risk, for stroke and ...

A transradial approach for cerebral angiography was less effective than the transfemoral route in achieving an accurate diagnostic success rate.

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

One patient with TNBC describes the challenges she faced trying to de-escalate a grueling treatment regimen despite warnings ...